Admission Date:  [**2126-6-30**]              Discharge Date:   [**2126-7-5**]  Date of Birth:  [**2051-11-19**]             Sex:   M  Service: MEDICINE  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 1055**] Chief Complaint: Dizziness, polyuria, polydipsia  Major Surgical or Invasive Procedure: None   History of Present Illness: 74 yr old male with hx of 2-vessel CAD s/p stent in [**2123**], HTN, high cholesterol who presents with 2 weeks of dizziness, blurry vision, polydipsia, polyuria and found to have a blood glucose of 1100, anion gap of 17.
In the ED, he received 2L of NS and 1L of NS with 40mEq of KCl.
He also received 10U of insulin x 1 and was started on an insulin drip.
Given his initial presentation with chest pain, cardiac enzymes were drawn and troponin was slightly elevated at 0.03.
Pt was admitted to the MICU for insulin drip.
CAD, 2-vessel disease s/p stenting of pLAD and diag 2.
Epigastric hernia; status post repair in [**2117-3-29**].
Sister with diabetes  Physical Exam: temp 98.5, BP 129/72, HR 89, R 22, O2 95% on 3L Gen: NAD, AO x 3 HEENT: PERRL, EOMI, MM slightly dry; on limited fundoscopic exam, no hemorrhages noted Neck: supple, no bruits CV: RRR, no g/m/r Chest: bibasilar crackles Abd: +BS, soft, NT, palpable mass beneath umbilicus the is more pronouced when pt bears down Ext: no edema, 1+ DP, sensation intact Neuro: CN 2-12 intact, [**4-2**] strenght in upper ext, [**3-2**] strenght in lower ext (though may be [**1-30**] poor cooperation), nl sensation, finger-nose-finger slow but accurate; gait not assessed   Pertinent Results: [**2126-6-30**] 03:40PM   GLUCOSE-1159* UREA N-54* CREAT-2.5*# SODIUM-126* POTASSIUM-6.6* CHLORIDE-87* TOTAL CO2-22 ANION GAP-24* [**2126-6-30**] 04:15PM   PT-12.0 PTT-24.6 INR(PT)-1.0 [**2126-6-30**] 03:40PM   cTropnT-0.03* [**2126-6-30**] 03:40PM   CK-MB-6 [**2126-6-30**] 03:40PM   WBC-9.9 RBC-5.14 HGB-16.1 HCT-50.9 MCV-99* MCH-31.3 MCHC-31.6 RDW-13.2  Brief Hospital Course: 1.
He was started on an insulin drip per protocol, and was admitted to the medical ICU for management of his fluid status, electrolytes, and blood sugar.
The MICU gained rapid control of his blood sugars, and he was transferred to the medical service for titration of insulin and disposition.
The department of Endocrinology from [**Last Name (un) **] Diabetes Center was consulted and made recommendations for insulin administration.
The patient was placed on Lantus insulin at bedtime, with a sliding scale of humalog insulin at mealtime.
Ultimately, the patient's son came to a family meeting and it was decided that he would have to perform the insulin injections for the patient.
[**Last Name (un) **] will coordinate further evaulation for podiatry and ophthalmology.
Hypertension:  The patient came to the hospital on an ACE-I and HCTZ.
Both medications were deemed appropriate, but both were held due to the patient's acute renal insufficiency.
The HCTZ remained held, and should be re-started once as an outpatient once full renal recovery has occurred, and where good BP monitoring can be achieved on a long-term basis.
His ACE-I was restarted as noted for renal protection and cardiac benefits.
FEN:  The patient was initially fluid repleted and placed on an insulin drip in the MICU.
The patient was placed on a diabetic diet, and was counseled on dietary requirements.
Prophylaxis:  The patient was placed on a PPI for his hospital stay.
He was given subcutaneous heparin for DVT prophylaxis.
Code status:  full code  Medications on Admission: ASA 81mg qd Flonase HCTZ 25mg qd Lipitor 20mg qd Lisinopril 5mg qd Lopressor 50mg [**Hospital1 **] NTG prn Ranitidine 150mg [**Hospital1 **]   Discharge Medications: 1.
Atorvastatin Calcium 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable PO DAILY (Daily).
Ranitidine HCl 150 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Metoprolol Tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Lisinopril 5 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Nitroglycerin 2.5 mg Capsule, Sustained Release Sig: [**12-30**] Capsule, Sustained Releases PO every four (4) hours as needed for chest pain.
Insulin Glargine 100 unit/mL Solution Sig: Twelve (12) units Subcutaneous at bedtime.
at bedtime: Use syringe for Glargine (Lantus) insulin administration.
Discharge Instructions: If you experience return of frequent urination, blurry vision, dizziness, chest pain, shortness of breath, fevers, chills, nausea, or vomiting, contact your physician or return to the Emergency Room.
